Neurocrine
「Neurocrine」熱門搜尋資訊
「Neurocrine」文章包含有：「NeurocrineBiosciences」、「Pipeline」、「NeurocrineBiosciences」、「NBIX」、「NeurocrineBiosciences」、「NewsReleases」、「自願公告百奧賽圖與NeurocrineBiosciences達成多靶點...」、「NeurocrineBiosciences,Inc.(NBIX)StockPrice」、「NeurocrineMedicalAffairs」、「NeurocrineBiosciences」
查看更多
Neurocrine Biosciences
https://www.neurocrine.com
Neurocrine Biosciences is dedicated to providing breakthrough treatments for patients in need with rare and under-addressed diseases.
Pipeline
https://www.neurocrine.com
A Robust Pipeline. Powered by Brave Science. Areas of investigation include potential new treatments in neurology, neuroendocrinology, and neuropsychiatry.
Neurocrine Biosciences
https://hk.finance.yahoo.com
Ingrezza was first approved in 2017 in its oral capsule formulation to treat adults with movement disorder tardive dyskinesia.
NBIX
https://www.moneydj.com
Neurocrine Biosciences, Inc.成立於1992年，總部設在加州的聖地牙哥。該公司在美國發掘並開發用於的治療神經和內分泌有關疾病的藥物。
Neurocrine Biosciences
https://en.wikipedia.org
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO ...
News Releases
https://neurocrine.gcs-web.com
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New ...
自願公告百奧賽圖與Neurocrine Biosciences達成多靶點 ...
https://www1.hkexnews.hk
根據協定，如果Neurocrine Biosciences行使選擇權，針對每個選定靶點，百奧賽. 圖將獲得選擇權行使費用、開發和商業化里程碑付款及個位數淨銷售額分成。
Neurocrine Biosciences, Inc. (NBIX) Stock Price
https://finance.yahoo.com
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United ...
Neurocrine Medical Affairs
https://www.neurocrinemedical.
Neurocrine Biosciences is committed to supporting the advancement of neurologic-, psychiatric-, and endocrine-related research through company-sponsored grants.
Neurocrine Biosciences
http://neurocrine.gcs-web.com
The Investor Relations website contains information about Neurocrine Biosciences's business for stockholders, potential investors, and financial analysts.